High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers von Ahlin, Cecilia, Lundgren, Claudia, Embretsén-Varro, Elin, Jirström, Karin, Blomqvist, Carl, Fjällskog, M. -L.

Volltext

Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values? von Ahlin, C, Aaltonen, K, Amini, R-M, Nevanlinna, H, Fjällskog, M-L, Blomqvist, C

Volltext

Nuclear osteopontin-c is a prognostic breast cancer marker von Zduniak, K, Ziolkowski, P, Ahlin, C, Agrawal, A, Agrawal, S, Blomqvist, C, Fjällskog, M-L, Weber, G F

Volltext

Experience in treatment of metastatic pulmonary carcinoid tumors von Granberg, D., Eriksson, B., Wilander, E., Grimfjärd, P., Fjällskog, M.-L., Öberg, K., Skogseid, B.

Volltext

P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME von Aakko, S., Ylitalo, A., Kuusanmäki, H., Björkman, M., Mandelin, J., Jalkanen, J., Fjällskog, M.‐L., Heckman, C., Hollmén, M., Kontro, M.

Volltext

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort von Niméus‐Malmström, E., Koliadi, A., Ahlin, C., Holmqvist, M., Holmberg, L., Amini, R.‐M., Jirström, K., Wärnberg, F., Blomqvist, C., Fernö, M., Fjällskog, M.‐L.

Volltext

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides von AALTONEN, K, AHLIN, C, AMINI, R.-M, SALONEN, L, FJÄLLSKOG, M.-L, HEIKKILÄ, P, NEVANLINNA, H, BLOMQVIST, C

Volltext

Cyclin A Is a Proliferative Marker with Good Prognostic Value in Node-Negative Breast Cancer von AHLIN, Cecilia, WENJING ZHOU, HOLMQVIST, Marit, HOLMBERG, Lars, NILSSON, Cecilia, JIRSTRÖM, Karin, BLOMQVIST, Carl, AMINI, Rose-Marie, FJÄLLSKOG, Marie-Louise

Volltext

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs von Fjällskog, M L, Sundin, A, Westlin, J E, Oberg, K, Janson, E T, Eriksson, B

Volltext

Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort von Niméus-Malmström, E., Koliadi, A., Ahlin, C., Holmqvist, M., Holmberg, L., Amini, R., Jirström, K., Wärnberg, F., Blomqvist, C., Fernö, M., Fjällskog, M.

Volltext

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors von Fjällskog, Marie‐Louise H., Granberg, Dan. P. K., Welin, Staffan L. V., Eriksson, Christopher, Kjell E. Öberg, Janson, Eva T., Eriksson, Barbro K.

Volltext

Colored body images reveal the perceived intensity and distribution of pain in women with breast cancer treated with adjuvant taxanes: a prospective multi-method study of pain expe... von Hellerstedt-Börjesson, Susanne, Nordin, Karin, Fjällskog, Marie-Louise, Rissanen, Ritva, Peterson, Magnus, Arving, Cecilia

Volltext

Abstract P1-17-01: Whole genome methylation patterns in male and female breast cancer – Unexpected findings von Johansson, I, Lauss, M, Holm, K, Nilsson, C, Fjällskog, M-L, Ringnér, M, Hedenfalk, I

Volltext

Abstract P3-02-02: Cyclin D1 overexpression increases the risk for breast cancer death 4-fold in hormone receptor positive and node negative breast cancer von Ahlin, C, Grönberg, M, Valachis, A, Zhou, W, Amini, R-M, Blomqvist, C, Fjällskog, M-L

Volltext

Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden) von Nilsson, Cecilia, Holmqvist, Marit, Bergkvist, Leif, Hedenfalk, Ingrid, Lambe, Mats, Fjällskog, Marie-Louise

Volltext

Lack of relationship between systemic exposure for the component drugs of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients von SANDSTRÖM, M, FREIJS, A, LARSSON, R, NYGREN, P, FJÄLLSKOG, M.-L, BERGH, J, KARLSSON, M. O

Volltext

Paclitaxel-induced cytotoxicity—the effects of cremophor EL (castor oil) on two human breast cancer cell lines with acquired multidrug resistant phenotype and induced expression of... von Fjällskog, M.-L., Frii, L., Bergh, J.

Volltext

P4-19-06: Ghrelin Expression Is Associated with Favorable Outcome in Male Breast Cancer von Grönberg, M, Nilsson, C, Johansson, I, Hedenfalk, I, Janson, ET, Fjällskog, M-L

Volltext

Is Cremophor EL, solvent for paclitaxel, cytotoxic? von Fjällskog, Marie-Louise, Frii, Lena, Bergh, Jonas

Volltext

P4-19-04: Evaluation of Histopathological Parameters in Male Breast Cancer Reveals Differences Compared with Female Breast Cancer von Nilsson, C, Johansson, I, Ahlin, C, Thorstenson, S, Bergkvist, L, Amin, R-M, Holmqvist, M, Hedenfalk, I, Fjällskog, M-L

Volltext